Added to YB: 2025-01-09
Pitch date: 2025-01-07
COV.V [neutral]
Covalon Technologies Ltd.
-40.22%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
Market Cap
CAD 65.8M
Pitch Price
CAD 3.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.34
P/E
27.87
EV/Sales
1.48
Sector
Biotechnology
Category
growth
Covalon Technologies ($COV.V) FINS Review
COV.V (u/g to 3.5 stars): Q4 revenue +35% YoY to $8.85M, GP margin +1600bps to 60%, op expenses -18.7%. FY2024: revenue +30% to $31M, OCF +$6.5M YoY. Strong balance sheet: 7.4x current ratio, $16.7M cash, zero debt. 49% insider ownership. Trades at 2.7x P/S, 31x P/E (18x P/E based on last 3Q).
Read full article (4 min)